Metabolic Diseases  >>  cyclosporine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00003662: Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Completed
2
90
US
anti-thymocyte globulin, busulfan, cyclophosphamide, cyclosporine, melphalan, methylprednisolone, umbilical cord blood transplantation, radiation therapy
Roswell Park Cancer Institute, National Cancer Institute (NCI)
Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Thymic Carcinoma
01/01
01/01
NCT00790439: Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant

Withdrawn
2
0
US
Low Molecular Weight Sulfated Dextran, LMW-SD, Heparin, Heparin Sodium, Mycophenolate Mofetil, MMF, Mycophenolate, Mycophenolic Acid, CellCept, Sirolimus, Rapamune, Tacrolimus, Hecoria, Cyclosporine, Ciclosporin, GENGRAF® Capsules, Daclizumab, Basiliximab, Simulect ®, Allogeneic Pancreatic Islet Cells
National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus, Type I
10/09
10/09

Download Options